Ringworm Explained: It’s Not a Worm – What It Actually Is, Where It Spreads, and How to Treat It

Ringworm is one of those medical terms that causes instant confusion. It sounds like a parasitic infection caused by an actual worm. It isn’t. Ringworm has nothing to do with worms – it’s a fungal infection of the skin, named centuries ago for the ring-shaped rash it typically produces.

This matters because the confusion leads people to the wrong treatments, unnecessary anxiety about parasites, and sometimes delayed appropriate antifungal therapy. Ringworm is extremely common, easily transmissible, and very treatable – but only when it’s correctly understood.

What Ringworm Actually Is

Ringworm is caused by dermatophytes – a group of fungi that infect keratinised tissue (skin, hair, and nails). The main causative organisms are species from three genera: Trichophyton, Microsporum, and Epidermophyton.

These fungi don’t invade living tissue – they digest keratin, the structural protein of the outer skin layer, hair shafts, and nail plates. The immune system’s response to fungal invasion and its byproducts produces the characteristic inflammation and the ring-shaped rash.

The term “tinea” (Latin for “worm” or “moth”) is the clinical term used with a body location descriptor – giving different names to the same fungal infection depending on where it occurs:

These are all the same type of infection – dermatophytosis – just in different locations. Understanding this matters for treatment, because the same antifungal agents work across these presentations, but the choice of formulation and duration differs by site.

How Dermatophytes Spread

Dermatophytes spread through three routes:

Human-to-human (anthropophilic dermatophytes): Direct skin contact with an infected person or indirect contact with their shed skin cells on surfaces, clothing, towels, or combs. Trichophyton rubrum (the most common cause of athlete’s foot and nail infection globally) spreads this way.

Animal-to-human (zoophilic dermatophytes): Contact with infected animals – particularly cats, dogs, cattle, and guinea pigs. Microsporum canis, commonly carried by cats and dogs, is a frequent cause of tinea capitis and tinea corporis in children who have contact with pets. Animal-source ringworm often produces a more inflammatory reaction than human-source infection.

Soil-to-human (geophilic dermatophytes): Contact with infected soil. Less common. Microsporum gypseum is the main geophilic species.

High-risk environments for spread:

• Communal showers, swimming pools, locker rooms (athlete’s foot/tinea pedis)
• Schools and day care centres (tinea capitis in children)
• Contact sports (wrestling, judo) – direct skin-to-skin contact (tinea corporis in athletes, sometimes called “tinea gladiatorum”)
• Close contact with infected pets
• Sharing towels, combs, hats, or clothing with infected individuals

Recognising Ringworm: What It Looks Like

Tinea Corporis (Body Ringworm)

The classic presentation: a round or oval, red, scaly ring with a clearer centre – the “ring” that gave the infection its name. The edge of the ring is typically more inflamed (raised, red, scaly) than the centre, which may partially clear as the infection spreads outward. Multiple rings can appear and sometimes merge.

The appearance varies by inflammatory response – zoophilic and geophilic infections typically produce more inflammation (vesicles, pustules, intense redness) than anthropophilic infections.

Tinea Capitis (Scalp Ringworm)

Primarily a condition of children (most common between ages 3-7), though adults can be affected. Presents as:

• Scaly, itchy patches on the scalp with broken hair shafts (hairs break off close to the scalp)
• Circular areas of hair loss (alopecia)
• “Black dot” pattern (broken hairs leaving black dots at scalp level) – characteristic of endothrix infection (fungus invading inside the hair shaft)
• Kerion: a severely inflamed, boggy, pustular mass that represents a strong immune response to the fungus. Kerions can cause permanent scarring alopecia if not treated promptly.

Tinea capitis is more common in sub-Saharan Africa and parts of Asia than in Europe and North America, and the causative organisms vary by geography.

Tinea Pedis (Athlete’s Foot)

The most common dermatophyte infection globally. Three clinical patterns:

Interdigital: Most common. Maceration, scaling, itching, and sometimes fissuring between the toes – particularly the fourth and fifth toe spaces.

Moccasin type: Chronic scaling, thickening, and mild redness covering the sole, heel, and sides of the foot in a “moccasin” distribution. Often bilateral. Caused predominantly by Trichophyton rubrum.

Vesicular: Itchy blisters (vesicles) on the sole and sides of the foot. More acute presentation.

Athlete’s foot is the primary source of toenail fungal infection – untreated foot infection commonly spreads to nails over months to years.

Tinea Cruris (Jock Itch)

Affects the groin, inner thighs, and perianal area. Produces a red-brown, scaly rash with a raised, advancing edge that spreads outward from the groin crease. More common in males. Often associated with concurrent tinea pedis – the fungus is typically transferred from the feet to the groin (put on underwear after touching infected feet). The scrotum and penis are usually spared (unlike Candida intertrigo, which affects the scrotum).

Diagnosis

Ringworm is often diagnosed clinically based on appearance. Confirmation with laboratory testing is appropriate when:

• The diagnosis is uncertain
• The presentation is atypical
• Treatment has failed despite appropriate therapy
• Tinea capitis is suspected (requires oral treatment and species identification)

KOH microscopy: Skin scrapings, hair samples, or nail clippings dissolved in KOH and examined for fungal hyphae or spores. Fast and widely available. Sensitivity approximately 70-80%.

Wood’s lamp: Some dermatophyte species fluoresce under Wood’s lamp UV light – Microsporum species produce green fluorescence in infected hairs. Trichophyton species (the most common globally) don’t fluoresce – so a negative Wood’s lamp doesn’t exclude tinea capitis.

Fungal culture: Identifies the species and guides treatment, particularly for tinea capitis where species identification affects treatment choice.

An important pitfall – tinea incognito: Ringworm that has been treated with topical corticosteroids (mistakenly prescribed or bought OTC without a diagnosis) loses its characteristic ring shape and becomes more widespread, less defined, and more difficult to recognise. This is called tinea incognito – a common reason for delayed diagnosis. If a rash worsened or became atypical after topical steroid use, fungal infection should be considered.

Treatment

Topical Antifungals – For Most Body and Foot Infections

Topical antifungals are effective for tinea corporis, tinea pedis, and tinea cruris. They’re applied to the rash and a margin of surrounding normal skin.

Azole antifungals (clotrimazole, miconazole, ketoconazole, econazole): Widely available OTC globally. Apply twice daily for 2-4 weeks for tinea corporis and cruris; 4 weeks for tinea pedis. Effective and well-tolerated.

Terbinafine 1% cream: Generally requires shorter treatment courses than azoles (1-2 weeks for tinea corporis; 1-2 weeks for tinea pedis interdigital). Often considered more effective than azoles for dermatophyte infections specifically.

Amorolfine, butenafine: Other topical antifungals effective for superficial dermatophyte infections.

Treatment should continue for at least 1-2 weeks after the rash appears to have resolved – stopping too early risks relapse from residual organisms.

Oral Antifungals – When Topicals Are Insufficient

Oral antifungals are required for:

• Tinea capitis – topicals don’t penetrate the hair shaft adequately; oral treatment is essential
• Extensive or widespread tinea corporis
• Infections not responding to adequate topical treatment
• Tinea unguium (nail infection) – covered in the fungal nail infection article
• Immunocompromised patients

Terbinafine: First-line for most dermatophyte infections. For tinea capitis: 250mg daily for 4-6 weeks (lower weight-based dosing in children). For tinea corporis: 250mg daily for 2-4 weeks.

Griseofulvin: Historically the primary oral treatment for tinea capitis, particularly for Microsporum species (which may respond less well to terbinafine). Still widely used in regions where terbinafine is less available or for specific species. Requires longer courses (6-12 weeks).

Itraconazole and fluconazole: Alternatives for specific situations – species resistance to terbinafine, patient intolerance, or Candida involvement.

Tinea Capitis: Specific Considerations

Tinea capitis requires oral antifungal treatment for at least 4-8 weeks. Topical treatment alone is insufficient. Additionally:

• Antifungal shampoo (ketoconazole or selenium sulfide) is used as adjunct to reduce spore shedding and prevent spread to household contacts and classmates – it doesn’t treat the infection but reduces transmission.
• Household contacts and close contacts should be examined and treated if infected.
• Shared items (combs, hats, pillowcases) should be disinfected or not shared during active infection.
• School exclusion: Policies vary by country. UK guidance (NICE) does not recommend excluding children with tinea capitis from school once treatment has started. Some other countries have different policies.
• Kerion (severe inflammatory tinea capitis) may require short-course oral corticosteroids alongside antifungals to reduce inflammation and prevent scarring.

Prevention

• Dry skin thoroughly after bathing, particularly between toes
• Wear flip-flops or sandals in communal showers, pool areas, and locker rooms
• Don’t share towels, combs, hats, or clothing
• Treat athlete’s foot promptly to prevent nail infection and spread
• Keep skin clean and dry, particularly in skin folds
• Have pets examined by a vet if they have scaly, hairless patches
• Wash hands after contact with animals
• Change socks daily; wear moisture-wicking materials
• Treat household members and close contacts if infection is identified

Frequently Asked Questions

Is ringworm dangerous? For most healthy people, ringworm is uncomfortable and unsightly but not dangerous. It’s self-limiting in some cases and responds well to treatment. The main complications are secondary bacterial infection from scratching, spread to other body areas or people, and in tinea capitis, permanent scarring alopecia from kerion or delayed treatment.

How long is ringworm contagious? Ringworm is contagious from the time of infection until the skin is adequately treated and no longer has active fungal organisms. Typically, people are no longer significantly contagious after 24-48 hours of appropriate antifungal treatment – though visible rash may take weeks to fully resolve. For tinea capitis, avoid sharing hair items until treatment is established.

Can ringworm come back after treatment? Yes – recurrence is common, particularly for athlete’s foot and nail infection. Recurrence typically results from re-exposure to the same environment (contaminated shoes, communal showers), untreated household contacts, or from a reservoir of infection in the nails spreading back to the skin. Addressing these sources reduces recurrence.

My child has ringworm on their scalp – do they need to stay home from school? Guidelines vary by country. In the UK, NICE guidance does not recommend exclusion from school once treatment has started and the child is well enough to attend. In some other countries, exclusion until treatment is established may be recommended. Check local public health guidance and inform the school so appropriate precautions can be taken.

Can I use hydrocortisone cream on ringworm? No. Hydrocortisone and other topical corticosteroids suppress the inflammatory response without killing the fungus. This temporarily reduces redness and itching but allows the fungus to spread unchecked – producing tinea incognito. Many over-the-counter combination products contain both an antifungal and a corticosteroid, which is occasionally appropriate for short-term use under medical guidance but shouldn’t be used indiscriminately for suspected ringworm.

Disclaimer

This article is for educational purposes only and does not constitute medical advice. Suspected tinea capitis in children should be evaluated by a healthcare provider, as oral treatment and laboratory confirmation are required. Skin conditions that don’t respond to appropriate treatment, or that worsen, should be evaluated by a qualified healthcare provider or dermatologist.

References

1. Hay RJ. Tinea capitis: current status. Mycopathologia. 2017;182(1-2):87-93. https://doi.org/10.1007/s11046-016-0058-8
2. Havlickova B, Czaika VA, Friedrich M. Epidemiological trends in skin mycoses worldwide. Mycoses. 2008;51(Suppl 4):2-15. https://doi.org/10.1111/j.1439-0507.2008.01606.x
3. Nenoff P, Krüger C, Ginter-Hanselmayer G, Tietz HJ. Mycology – an update. Part 1: dermatomycoses: causative agents, epidemiology and pathogenesis. Journal der Deutschen Dermatologischen Gesellschaft. 2014;12(3):188-209. https://doi.org/10.1111/ddg.12229
4. NICE (National Institute for Health and Care Excellence). Fungal skin infection – body and groin. https://cks.nice.org.uk/topics/fungal-skin-infection-body-groin/
5. NICE. Fungal skin infection – scalp. https://cks.nice.org.uk/topics/fungal-skin-infection-scalp/
6. World Health Organization (WHO). Skin conditions. https://www.who.int/news-room/fact-sheets/detail/skin-diseases
7. Ely JW, Rosenfeld S, Seabury Stone M. Diagnosis and management of tinea infections. American Family Physician. 2014;90(10):702-710. https://www.aafp.org/pubs/afp/issues/2014/1115/p702.html
8. Seebacher C, Bouchara JP, Mignon B. Updates on the epidemiology of dermatophyte infections. Mycopathologia. 2008;166(5-6):335-352. https://doi.org/10.1007/s11046-008-9100-9
9. Gupta AK, Cooper EA. Update in antifungal therapy of dermatophytosis. Mycopathologia. 2008;166(5-6):353-367. https://doi.org/10.1007/s11046-008-9109-0
10. MedlinePlus. Tinea infections. https://medlineplus.gov/tineainfections.html